pharm quiz 1 Flashcards

1
Q

Induce or expose a functional group on the parent compound is by what three

A

oxidation, reduction, hydrolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is oxidation

A

loss of electrons via split O2 molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is reduction

A

gain electrons via electron transfer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is hydrolysis

A

addition of water to break bonds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what does hydrolyzing or ester linking for rapid elimination do

A

increase ionization to pass thru kidneys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are some functional groups

A

glucouronic acid, sulfate, glutatione, amino acid, acetate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

cytochrome=

A

iron containing hemoprotein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

450=

A

peak absorption at 450nm when reacting with carbon monoxide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what CYP450 isoform has the greatest breakdown of meds in bodys, is not most abundant

A

CYP3A4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Drug receptors are

A

Proteins or glycoproteins present on cell surface, on an organelle within the cell, or in the cytoplasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Second messengers examples

A

CAMP, cGMP, Ca, inositol phosphates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Inverse agonist

A

Bonds to receptor site and causes the opposite effect of an agonist
Ex H2 receptor antagonists

It doesn’t block anything from happening, it stops the effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Competitive antagonist is

A

Surmountable, agonists cannot bind to receptor antagonist is mounted until overcome by high doe-se

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Irreversible antagonist

A

Agents compete with agonists for the agonist binding receptor.
Permanent binding with receptor
Anti plt meds wait 7 days for new pots to be activated.
Nerve gas permanent paralysis until new muscarinic and nicotinic receptors generated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Category a pregnancy

A

Adequate and well controlled studies have failed to demonstrate a risk to the fetus in first trimester and later trimesters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Category b pregnancy

A

Animal studies have failed to demonstrate a risk to the fetus and there are no adequate and well controlled studies in pregnant women

17
Q

Category c pregnancy

A

Animal studies have shown adverse effect on fetus and there are no adequate and well controlled studies in humans but potential benefits may warrant use of drug despite potential risks

18
Q

Category d pregnancy

A

There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use despite risks ie antiseizure and mood stabilizer can cause spina bífida cardiacs abnormalities

19
Q

Category x preg

A

Studies demonstrated fetal risks and the risks clearly outweigh potential benefits ie warfarin
Use lovenox for dvt preg women

20
Q

REMS

A

Risk evaluation and mitigation strategy- tracking of drugs in community and finding safer ways to administer

21
Q

Altered metabolism

A

P450 isoenzymes inhibited ir índices by drug interactions

22
Q

Plasma protein competition

A

Drugs compete for binding of plasma proteins. Can increase concentration of drug unbound due to competition to toxic levels

23
Q

Altered absorption

A

Drugs may inhibit absorption of other drugs across biological membranes (anti ulcer agents that coat the stomach may decrease go absorption of other drugs

24
Q

Altered excretion

A

Drugs may act on the kidney to reduce excretion of specific agents ( probenecid competes with sulfonamides for the same carrier, increasing the risk of sulfonamide toxicity)

25
Q

Tolerance can be

A

Metabolic and cellelular

26
Q

Metabolic tolerance

A

Drug is metabolized more rapidly after chronic use

27
Q

Cellular tolerance

A

Decreases number of receptors “downregulation”

28
Q

Metabolism can make medications more

A

Active (prodrug) or inactive or metabolites may be more toxic than parent compound